FULGENT GENETICS, INC.: gross profit
Gross profit for FULGENT GENETICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All FULGENT GENETICS, INC. financial histories
What this measure means
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
Exact concept: us-gaap:GrossProfit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2014-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 130,875,000 | USD | 2026-02-27 | 10-K · 0001193125-26-079169 |
| 2024-01-01 | 2024-12-31 | 107,215,000 | USD | 2026-02-27 | 10-K · 0001193125-26-079169 |
| 2023-01-01 | 2023-12-31 | 104,456,000 | USD | 2026-02-27 | 10-K · 0001193125-26-079169 |
| 2022-01-01 | 2022-12-31 | 366,901,000 | USD | 2025-02-28 | 10-K · 0000950170-25-029512 |
| 2021-01-01 | 2021-12-31 | 777,051,000 | USD | 2024-02-28 | 10-K · 0000950170-24-022233 |
| 2020-01-01 | 2020-12-31 | 331,905,000 | USD | 2023-02-28 | 10-K · 0000950170-23-005178 |
| 2019-01-01 | 2019-12-31 | 18,421,000 | USD | 2022-02-28 | 10-K · 0001564590-22-007366 |
| 2018-01-01 | 2018-12-31 | 10,654,000 | USD | 2020-03-13 | 10-K · 0001564590-20-010617 |
| 2017-01-01 | 2017-12-31 | 10,179,000 | USD | 2019-03-22 | 10-K · 0001564590-19-008991 |
| 2016-01-01 | 2016-12-31 | 11,554,000 | USD | 2018-03-20 | 10-K · 0001564590-18-006239 |
| 2015-01-01 | 2015-12-31 | 4,507,000 | USD | 2017-03-17 | 10-K · 0001564590-17-004681 |
| 2014-01-01 | 2014-12-31 | 342,000 | USD | 2017-03-17 | 10-K · 0001564590-17-004681 |
Related financial histories
- FULGENT GENETICS, INC.: total assets
- FULGENT GENETICS, INC.: total liabilities
- FULGENT GENETICS, INC.: stockholders equity
- FULGENT GENETICS, INC.: cash and cash equivalents
- FULGENT GENETICS, INC.: net income or loss
- FULGENT GENETICS, INC.: operating cash flow
- FULGENT GENETICS, INC.: capital expenditure payments
- FULGENT GENETICS, INC.: revenue
- FULGENT GENETICS, INC.: contract revenue excluding tax
- FULGENT GENETICS, INC.: financing cash flow
- FULGENT GENETICS, INC.: investing cash flow
- FULGENT GENETICS, INC.: retained earnings or deficit
- FULGENT GENETICS, INC.: basic weighted-average shares
- FULGENT GENETICS, INC.: diluted weighted-average shares
- FULGENT GENETICS, INC.: income tax expense or benefit
- FULGENT GENETICS, INC.: net property, plant and equipment
- FULGENT GENETICS, INC.: share-based compensation expense
- FULGENT GENETICS, INC.: operating income or loss
- FULGENT GENETICS, INC.: current assets
- FULGENT GENETICS, INC.: interest expense
- FULGENT GENETICS, INC.: current liabilities
- FULGENT GENETICS, INC.: current accounts payable
- FULGENT GENETICS, INC.: goodwill carrying amount
- FULGENT GENETICS, INC.: net finite-lived intangible assets
- FULGENT GENETICS, INC.: net current accounts receivable
- FULGENT GENETICS, INC.: common-stock repurchase payments
- FULGENT GENETICS, INC.: operating expenses
- FULGENT GENETICS, INC.: cost of revenue
- FULGENT GENETICS, INC.: research and development expense
Inspect the source
- Entity
- FULGENT GENETICS, INC. / CIK 0001674930
- Captured
- 2026-09-21T17:24:35.102Z
- SEC response SHA-256
134af1b65e64f3ae050f6d95e2f0b88ddb1b0a3533a3f5933ae06dd4a719b415
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001674930.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))